×
Organon Share Holder Equity 2019-2025 | OGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Organon share holder equity from 2019 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
View More
Organon Share Holder Equity 2019-2025 | OGN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Organon share holder equity from 2019 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$145.3B
CVS Health (CVS)
$75.4B
Elevance Health (ELV)
$64.4B
Cencora (COR)
$55.5B
DiDi Global (DIDIY)
$26B
Labcorp Holdings (LH)
$21.9B
Natera (NTRA)
$18.8B
BioMerieux (BMXMF)
$17.1B
ICON (ICLR)
$15.3B
EUROFINS SCIENT (ERFSF)
$14.9B
CochLear (CHEOY)
$13.4B
Solventum (SOLV)
$12.8B
Medpace Holdings (MEDP)
$12.7B
Revvity (RVTY)
$11.2B
Viatris (VTRS)
$10.9B
Avantor (AVTR)
$9.5B
Sonic Healthcare (SKHHY)
$9.2B
Charles River Laboratories (CRL)
$8.8B
HealthEquity (HQY)
$8.3B
Caris Life Sciences,�Inc (CAI)
$6.9B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$5.1B
BrightSpring Health Services (BTSG)
$3.6B
Sotera Health (SHC)
$3.5B
Surgery Partners (SGRY)
$2.9B
Concentras Parent (CON)
$2.6B
GeneDx Holdings (WGS)
$2.4B
Alignment Healthcare (ALHC)
$2.3B
Progyny (PGNY)
$2B
PACS (PACS)
$1.8B